A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Fluticasone furoate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 25 Oct 2017 Status changed from not yet recruiting to recruiting.
- 23 Oct 2017 Planned initiation date changed from 4 Oct 2017 to 31 Oct 2017.
- 16 Aug 2017 New trial record